MASH patients share their hopes and challenges in new interview study

NCT ID NCT07188220

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study interviews 25 people with MASH (a fatty liver disease linked to metabolism) to learn about their expectations, attitudes, and unmet needs before and after joining a special heart-liver program. Participants will have two private interviews. The goal is to improve care by hearing directly from patients, not to test any new drug or treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

metabolic dysfunction-associated steatohepatitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • IR Sant Pau

    RECRUITING

    Barcelona, 08041, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • IR Sant Pau

    RECRUITING

    Barcelona, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••